Does Blue Cross Blue Shield of Michigan Cover Liraglutide (Saxenda)?
A detailed guide to BCBS Michigan Saxenda coverage, prior authorization requirements, formulary tiers, appeal rights, and cost-reduction strategies for liraglutide 3 mg.
How Long Does It Take for Semaglutide to Work?
A timeline showing when semaglutide starts affecting appetite, blood sugar, and body weight, what the pivotal trials found, and how to tell true non-response from a treatment that just needs more time.
How Do I Download and Set Up the Calibrate App?
Step-by-step guide to downloading and setting up the Calibrate app, including eligibility screening, GLP-1 medication onboarding, device syncing, and how to get the most from your first 90 days.
How Do I Locate the FAQs in the Calibrate App? | Calibrate
Step-by-step guide to finding the FAQ section inside the Calibrate app, plus what Calibrate's GLP-1 program covers, how the app supports medication adherence, and when to contact your care team instead.
How Should Common GLP-1 Gastrointestinal Side Effects Be Managed
A guide to managing nausea, vomiting, diarrhea, constipation, and other GI side effects from GLP-1 receptor agonists, with dose strategies, dietary changes, and red-flag signs, plus a structured decision path for when to escalate care.
How to Build and Maintain Healthy Habits
A guide to building and sustaining healthy habits using behavioral science, practical frameworks, and evidence-based strategies for long-term health.
What Are the First Signs of PCOS? Early Symptoms Explained
PCOS early symptoms include irregular periods, excess hair growth, acne, and weight changes. Learn the first signs of polycystic ovary syndrome, how they are diagnosed, and what treatment options exist.
What Are Uterine Fibroids? Causes and Symptoms Explained
A guide to uterine fibroids: what they are, why they develop, how they present, and what current evidence says about diagnosis and management options.
What Exactly Are GLP-1 Receptor Agonists?
A guide to GLP-1 receptor agonists: how they work, which drugs are approved, what the clinical trials show, and who qualifies for treatment.
What Is Broad Care? Why a Broad Approach to Health Actually Works
Broad care treats the whole person rather than isolated symptoms. This article explains what whole-person care means clinically, how it differs from single-issue visits, and what the evidence does and does not support about treating hormonal, metabolic, and mental health factors together.
What You Need to Know About Getting Your Weight-Loss Medication
A guide covering GLP-1 agonists, eligibility criteria, prescribing pathways, safety data, costs, and what to expect before your first dose of weight-loss medication.
Why Intermittent Fasting Isn't Working for Men Over 35: The First Optimal Fix
Intermittent fasting stops working for men over 35 because of testosterone decline, cortisol dysregulation, muscle loss, and metabolic adaptation. This guide explains the exact mechanisms and the evidence-based fixes.
Why Intermittent Fasting Isn't Working for Women Over 35: The Hormonal Truth
Intermittent fasting often backfires for women over 35 because of cortisol, estrogen, and progesterone interactions. Learn what the research shows and what actually works instead.
Why It's Important to Get a Diabetic Eye Exam
Diabetic eye exams catch sight-threatening retinopathy, macular edema, glaucoma, and cataracts before symptoms appear. What the guidelines recommend, what the exam actually finds, and when to go sooner than the standard yearly schedule.
Lipitor Effect on ApoB: How Atorvastatin Changes Your ApoB Level
Atorvastatin (Lipitor) lowers ApoB by 35 to 50% at standard doses. Learn the mechanism, magnitude, time course, and how to monitor ApoB on statin therapy.
Wegovy Effect on Visceral Adipose Tissue (VAT): What the Clinical Data Show
Semaglutide 2.4 mg (Wegovy) significantly reduces visceral adipose tissue in clinical trials. Learn the magnitude, timeline, mechanism, and monitoring approach backed by RCT evidence.
Erectile Dysfunction: A Doctor's Guide for 2026
A comprehensive, evidence-graded guide to erectile dysfunction covering diagnosis, all treatment options, head-to-head comparisons, who shouldn't use each therapy, and monitoring protocols prepared by the HealthRX.com Editorial Team.
Leqvio (Inclisiran) and Autoimmune Disease: What Clinicians Need to Know
A clinical deep-dive into inclisiran (Leqvio) use in patients with autoimmune disease, covering safety data from ORION trials, immunogenicity findings, dosing considerations, and practical guidance for rheumatology-cardiology co-management.
Leqvio Cancer Risk Signal Review: What the Clinical Data Actually Show
A physician-level review of the inclisiran (Leqvio) cancer risk signal: ORION trial data, FDA labeling, post-marketing surveillance, and how to counsel patients with ASCVD or familial hypercholesterolemia.
Leqvio Cognitive Function Impact: What the Evidence Actually Shows
A clinical deep-dive into inclisiran (Leqvio) and cognitive function. Covers ORION trial data, PCSK9 inhibitor cognitive safety evidence, FDA labeling, and how to counsel patients asking whether Leqvio affects memory or thinking.
Leqvio (Inclisiran): How to Safely Stop
A guide to discontinuing inclisiran (Leqvio), covering LDL rebound timelines, bridging strategies, cardiovascular risk management, and when stopping is medically appropriate.
Does Humana Cover Leqvio (Inclisiran)? Coverage, Prior Auth, and Appeals Guide
A guide to Humana coverage of Leqvio (inclisiran) for ASCVD and familial hypercholesterolemia, including formulary tiers, prior-authorization criteria, step-therapy requirements, and how to appeal a denial.
Leqvio Liver Function Impact: What Inclisiran Does (and Does Not Do) to Your Liver
A clinician-level review of inclisiran (Leqvio) liver function impact, covering ALT/AST data from ORION-10, ORION-11, and ORION-3, hepatic metabolism, and what to monitor before and after dosing.
Canagliflozin (Invokana): How It Works, Doses, Benefits, and Risks
A guide to canagliflozin (Invokana) covering mechanism, dosing, cardiovascular and renal outcomes, side effects, and how it compares with metformin, glipizide, pioglitazone, and empagliflozin.
SGLT2 Inhibitor DKA Prevention: Sick-Day and Surgery Rules
SGLT2 inhibitors can cause euglycemic DKA even with normal glucose. Learn sick-day holding rules, pre-surgical hold timing, and ketone monitoring guidance.
Lantus vs Basaglar: Differences, Dosing, and Cost
Lantus and Basaglar share the same insulin glargine sequence and 100 U/mL strength but differ in price and pen device; Toujeo is 300 U/mL. Compare dosing here.
Metformin Titration and Tolerance: A Clinical Dosing Guide
Learn how to titrate metformin safely, manage GI side effects, and understand how it fits into basal-bolus insulin regimens, carb counting, and insulin-to-carb ratio calculations.
Metformin vs GLP-1 Agonists: A Clinical Comparison for Type 2 Diabetes and Weight Management
A comparison of metformin and GLP-1 receptor agonists covering mechanism, efficacy, weight loss, cardiovascular outcomes, side effects, cost, and when to use each drug or both together.
Humalog Reviews: How It Compares to Novolog
Humalog and Novolog work almost identically for mealtime blood sugar control. See what matters more: insurance coverage, device fit, and daily routine.
Pioglitazone (Actos): Dosing, Mechanism, Side Effects, and How It Compares to Metformin, SGLT2 Inhibitors, and Sulfonylureas
Complete clinical guide to pioglitazone (Actos) for type 2 diabetes: mechanism, dosing, side effects, cardiovascular data, and head-to-head comparisons with metformin, glipizide, empagliflozin, and dapagliflozin.
Tresiba Dosing for Adults 30-49: Units and Titration Steps
For adults 30-49, Tresiba starts at 10 units daily for insulin-naive type 2 diabetes, or 80% of prior basal dose when converting, adjusted per fasting glucose.
Lantus Cost vs Alternatives: Insulin Glargine Price and Clinical Comparison Guide
Compare Lantus (insulin glargine) cost against biosimilars, other basal insulins, and GLP-1 combinations. Includes mechanism, dosing, trial data, and a clinical decision framework for switching.
Alprostadil (Caverject/MUSE) and Simvastatin Interaction: What Patients and Clinicians Need to Know
A detailed clinical review of the alprostadil and simvastatin drug interaction, covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling based on FDA labels and primary literature.
Amlodipine With Levothyroxine: Food Timing, Supplements and Thyroid Checks
Coordinate amlodipine and levothyroxine around breakfast, calcium and iron. A timing worksheet separates product instructions from assumed interactions.
Amlodipine and Opioids (Oxycodone, Hydrocodone, Tramadol): Drug Interaction Guide
A breakdown of the amlodipine, opioid interaction covering mechanism, severity, monitoring parameters, dose-adjustment principles, and patient counseling for oxycodone, hydrocodone, and tramadol.
Amlodipine and Prednisone Interaction: What Patients and Clinicians Need to Know
A guide to the amlodipine and prednisone drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling.
Amlodipine and Sildenafil Interaction: What Patients and Clinicians Need to Know
A guide to the amlodipine and sildenafil drug interaction: mechanism, hypotension risk, monitoring parameters, dose adjustments, and patient counseling points backed by primary literature.
Vyleesi Cannabis Interaction Profile: What You Need to Know Before Combining Bremelanotide and Cannabis
A guide to the bremelanotide (Vyleesi) and cannabis drug interaction, covering pharmacokinetics, nausea risk amplification, blood pressure effects, and safe-use recommendations.
Vyleesi and Testosterone Interaction: What Clinicians and Patients Need to Know
A clinician-level review of the bremelanotide and testosterone drug interaction, covering pharmacokinetics, pharmacodynamic overlap, monitoring parameters, and patient counseling guidance.
Cialis and Rosuvastatin Interaction: What Patients and Clinicians Need to Know
A guide to the tadalafil and rosuvastatin drug interaction: mechanism, severity, OATP1B1/1B3 pharmacokinetics, clinical evidence, dose guidance, and monitoring recommendations.
Cialis and SSRIs (Sertraline, Escitalopram): Drug Interaction Guide
Can you take Cialis (tadalafil) with SSRIs like sertraline or escitalopram? A guide covering mechanism, serotonin syndrome risk, dosing, and monitoring.
Trulicity and Imaging Contrast Dye: What Patients and Clinicians Need to Know
A clinical guide to the interaction between dulaglutide (Trulicity) and iodinated contrast dye, including when to hold the medication, which patients face the highest risk, and what current guidelines recommend.
Trulicity and Gabapentin Interaction: What Patients and Clinicians Need to Know
A guide to the dulaglutide (Trulicity) and gabapentin drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling for type 2 diabetes management.
Trulicity and PPIs (Omeprazole, Pantoprazole): Interaction Guide
A guide on the clinical interaction between dulaglutide (Trulicity) and proton pump inhibitors (omeprazole, pantoprazole), covering mechanism, safety, monitoring, and patient counseling.
Avodart Anesthesia and Perioperative Interaction: What Patients and Clinicians Need to Know
A complete clinical guide to dutasteride (Avodart) interactions with anesthesia and perioperative medications, including evidence-based guidance on whether to hold the drug before surgery.
Avodart and Progesterone HRT Interaction: What Patients and Clinicians Need to Know
What is established, what is plausible but unproven, and what remains unverified about combining dutasteride (Avodart) with oral micronized progesterone HRT: mechanisms, sedation risk, shared metabolic pathway, and monitoring points.
Oral Estradiol and Cannabis Interaction Profile: What You Need to Know
A guide to the pharmacokinetic and pharmacodynamic interactions between oral estradiol and cannabis (THC/CBD), including CYP1A2/CYP3A4 effects, nausea, cardiovascular risks, and practical dosing guidance.
Finasteride and Gabapentin Interaction: What Patients and Clinicians Need to Know
A guide to the finasteride and gabapentin drug interaction: pharmacokinetics, pharmacodynamics, CNS sedation risk, renal considerations, monitoring, and patient counseling.
Finasteride and NSAIDs (Ibuprofen, Naproxen): Interaction Guide
Can you take finasteride with ibuprofen or naproxen? A deep dive into the pharmacology, renal risks, GI concerns, and clinical monitoring guidance for combining finasteride with NSAIDs.
Leqvio and Metformin Interaction: What Patients and Clinicians Need to Know
A clinical deep-dive into the inclisiran (Leqvio) and metformin drug interaction: mechanism, safety profile, monitoring parameters, and patient counseling based on FDA labeling and primary literature.
Accutane (Isotretinoin) and Tadalafil Interaction: What Patients and Prescribers Need to Know
A deep-dive into the isotretinoin, tadalafil drug interaction: mechanism, cardiovascular risk, monitoring parameters, dose guidance, and patient counseling points backed by primary literature.
Tirosint Nicotine Interaction Profile: What Thyroid Patients Need to Know
Does nicotine affect Tirosint (levothyroxine liquid gel cap) absorption or thyroid hormone levels? Full clinical breakdown of the nicotine-levothyroxine interaction, with dosing guidance and monitoring protocols.
Lisinopril and Sildenafil Interaction: What Patients and Clinicians Need to Know
A guide to the lisinopril and sildenafil drug interaction: mechanism, severity, real trial data, monitoring parameters, dose guidance, and patient counseling points.
Low-Dose Naltrexone and NSAIDs (Ibuprofen, Naproxen): Drug Interaction Guide
Can you take low-dose naltrexone with ibuprofen or naproxen? A guide covering the pharmacology, real risks, monitoring requirements, and patient counseling for this drug combination.
Metformin and Benzodiazepines Interaction: What Patients and Clinicians Need to Know
A guide to the metformin and benzodiazepines interaction, covering mechanism, severity, monitoring parameters, dose adjustments, and patient counseling backed by primary literature.
MK-677 (Ibutamoren) and Acetaminophen Interaction: What You Need to Know
A guide to the MK-677 (ibutamoren) and acetaminophen drug interaction, covering hepatic toxicity overlap, CYP enzyme effects, monitoring, dosing, and patient counseling.
MOTS-c Anesthesia and Perioperative Interaction: What Patients and Clinicians Need to Know
A guide to MOTS-c mitochondrial peptide interactions with anesthesia and perioperative care, including evidence-based dosing guidance, metabolic considerations, and perioperative management protocols.
Mounjaro Vaccine Interaction Profile: What Clinicians and Patients Need to Know
A guide to tirzepatide (Mounjaro) and vaccine interactions, covering immunogenicity data, timing recommendations, flu shots, COVID-19 vaccines, shingles vaccines, and alcohol use while on GLP-1/GIP therapy.
Mounjaro and Opioids (Oxycodone, Hydrocodone, Tramadol): Interaction Guide
Can you take Mounjaro (tirzepatide) with opioids like oxycodone, hydrocodone, or tramadol? A guide covering mechanism, severity, monitoring, dose adjustment, and patient counseling with primary source citations.
Mounjaro and PPIs (Omeprazole, Pantoprazole): What You Need to Know
A clinical review of the tirzepatide and PPI interaction: mechanism, severity, monitoring, and patient counseling for omeprazole and pantoprazole co-administration.